Comparing philanthropic benefits, harms and grant proportions
A charitable portfolio can produce benefits in one setting and serious problems in another. Evaluating that possibility requires more than counting favorable stories, disfavored causes or dollars allocated to each.
Reviewed 17 October 2026. Financial figures and professional roles retain the dates stated in their sources.
Measure the same things
The Organisation for Economic Co-operation and Development (OECD) evaluates interventions through relevance, coherence, effectiveness, efficiency, impact and sustainability. Its framework treats impact as including beneficial and harmful consequences, whether intended or unintended. These questions can help organize a grant review, although the criteria do not automatically supply a measurement method or a verdict about a foundation. [1]
First define what counts as a benefit or harm and whose experience matters. A clinic visit, a research paper, an injury and a policy change are different measures. They cannot be combined into a meaningful moral balance by subtracting their grant budgets. A cheap intervention may create major harm; an expensive intervention may fail to produce its promised benefit.
Test the spending claim
A claim that an organization gives small amounts to good causes and larger amounts to bad ones needs a defined portfolio, time period and classification system. Include grants that contradict the claim. Separate paid grants from promises and cash from estimated software discounts. Publish the categories and allow readers to see how a disputed award was classified.
The United States Government Accountability Office (GAO) distinguishes resources and delivered services from changes in people’s lives. Its 2026 review explains why clear goals and relevant outcome data are necessary and why stronger evaluation is needed to understand whether programs work. Apply that distinction to philanthropy: distributing training materials is an output; demonstrated improvement in learning is an outcome. [2]
Keep harm visible
The Charity Commission’s public-benefit guidance for England and Wales requires attention to evidence of benefit and management of risks of harm. That jurisdiction’s rules do not govern every American foundation, but they illustrate why a positive mission statement cannot resolve questions about implementation. Document who was harmed, what happened and the organization’s response. [3]
A useful review gives benefits, harms and uncertainty separate space. Show the strength of causal evidence, how long effects lasted, which groups were excluded and whether independent reviewers checked the findings. Where evidence is incomplete, the defensible conclusion is a limited one. Favorable activity cannot erase a substantiated abuse, and a substantiated abuse does not demonstrate that every other program is fraudulent.
Continue learning
How grant money moves: donors, sponsors and recipients